AGF Investments Inc’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,703
Closed -$1.78M 580
2021
Q4
$1.78M Buy
2,703
+418
+18% +$262K 0.01% 359
2021
Q3
$1.42M Buy
+2,285
New +$1.54M 0.01% 370
2020
Q3
Sell
-762
Closed -$252K 845
2020
Q2
$252K Hold
762
﹤0.01% 596
2020
Q1
$185K Sell
762
-149,033
-99% -$38.9M ﹤0.01% 623
2019
Q4
$39.1M Sell
149,795
-8,464
-5% -$2.23M 0.47% 72
2019
Q3
$43M Sell
158,259
-2,194
-1% -$611K 0.54% 68
2019
Q2
$44.2M Sell
160,453
-143,844
-47% -$35.4M 0.54% 70
2019
Q1
$68M Sell
304,297
-19,448
-6% -$4.01M 0.76% 44
2018
Q4
$60.2M Sell
323,745
-33,840
-9% -$6.94M 0.72% 50
2018
Q3
$89.3M Buy
357,585
+6,487
+2% +$1.57M 0.9% 32
2018
Q2
$76.5M Buy
351,098
+13,097
+4% +$2.7M 0.79% 41
2018
Q1
$64.7M Buy
338,001
+332,332
+5,862% +$61.3M 0.7% 45
2017
Q4
$887K Sell
5,669
-510
-8% -$80.3K 0.01% 311
2017
Q3
$961K Sell
6,179
-876
-12% -$138K 0.01% 295
2017
Q2
$1.14M Sell
7,055
-1,598
-18% -$260K 0.01% 275
2017
Q1
$1.34M Sell
8,653
-1,784
-17% -$246K 0.01% 279
2016
Q4
$1.22M Sell
10,437
-1,084
-9% -$124K 0.01% 290
2016
Q3
$1.3M Sell
11,521
-1,547
-12% -$163K 0.01% 293
2016
Q2
$1.21M Buy
13,068
+464
+4% +$39.8K 0.01% 290
2016
Q1
$986K Hold
12,604
0.01% 305
2015
Q4
$919K Sell
12,604
-1,927
-13% -$137K 0.01% 297
2015
Q3
$1.09M Buy
14,531
+531
+4% +$38K 0.01% 288
2015
Q2
$896K Sell
14,000
-800
-5% -$55.4K 0.01% 317
2015
Q1
$1.14M Buy
14,800
+4,200
+40% +$327K 0.01% 299
2014
Q4
$785K Buy
+10,600
New +$743K 0.01% 311

Other funds holding IDXX

AGF Investments Inc's IDXX Position: Q1 2022 in Review

AGF Investments Inc sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 2,703 shares — an estimated $1.78M sold.

AGF Investments Inc first reported a position in IDXX in Q4 2014 and held it in 25 quarters. The position peaked at $89.3M in Q3 2018. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • AGF Investments Inc reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 2,703 Idexx Laboratories shares in Q1 2022, an estimated $1.78M.
  • AGF Investments Inc first reported a position in Idexx Laboratories in Q4 2014 and held it in 25 quarters.
  • AGF Investments Inc's Idexx Laboratories position peaked at $89.3M in Q3 2018.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.